Quviviq
Payments companies reported to CMS as associated with Quviviq. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Quviviq, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Quviviq
These are the largest totals companies reported as associated with Quviviq. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Greg Friedman | Hallandale Beach, FL | Psychiatry | $105,261.27 |
| Shahrokh Javaheri | Cincinnati, OH | Sleep Medicine (Family Medicine) | $104,996.23 |
| Domingo Rodriguez-Cue | Garner, NC | Family Medicine | $103,720.84 |
| Alon Avidan | Los Angeles, CA | Neurology (Psychiatry & Neurology) | $100,679.50 |
| Rajkumar Dasgupta | Pasadena, CA | Pulmonary Disease | $95,691.83 |
| Scott Wiener | Greenfield, WI | Psychiatry | $83,904.69 |
| Damon Raskin | Pacific Palisades, CA | Internal Medicine | $72,848.86 |
| Abhinav Singh | Greenwood, IN | Internal Medicine | $66,819.00 |
| Michael Ledet | Daphne, AL | Sleep Medicine (Family Medicine) | $66,079.11 |
| Jeffrey Richmond | Denver, CO | Psychiatry | $64,091.78 |
Prescribed Quviviq?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.